Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2Phase 4 1

Status

Unknown 3Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 164Breast 93Thoracic 37Genitourinary 33Gynecologic 28Sarcoma 25Head & Neck 23CNS 19Plasma cell 6Lymphoid 6Tumor-Agnostic 5Other solid neoplasm 4Dermatologic 3Other hematologic neoplasm 1Endocrine 1Classical hematology 1

Conditions

Multiple Myeloma 6Recurrence 1Neoplasms, Plasma Cell 1

Interventions

Dexamethasone 870Lenalidomide 456Bortezomib 454Cyclophosphamide 365Melphalan 271Calcium Dobesilate 262daratumumab 233pomalidomide 207carfilzomib 182fludarabine phosphate 140fludarabine 136Thalidomide 125Peripheral Blood Stem Cell Transplantation 119Filgrastim 114ixazomib 93Mycophenolic Acid 90Granulocyte Colony-Stimulating Factor 89Whole-Body Irradiation 87Busulfan 87dexamethasone acetate 86Tacrolimus 78dexamethasone 21-phosphate 74Cyclosporine 68isatuximab 67auricularum 67Prednisone 65elotuzumab 58belantamab mafodotin 56Antilymphocyte Serum 56Etoposide 53

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × Neoadjuvant Therapy × Plasma cell × Clear all
NCT07149857 2026-05-08

CARTITUDE-10

Janssen Research & Development, LLC

Phase 2 Recruiting
60 enrolled
Plasma cell

Multiple Myeloma

NCT02572492 2018-08-17

CARFI

Aalborg University Hospital

Phase 2 Unknown
200 enrolled
Plasma cell

Multiple Myeloma, Recurrence

NCT01852799 2018-08-10

A Study of PAD Followed by Autologous Stem Cell Transplantation (ASCT) to Treat Newly Diagnosed Multiple Myeloma

Shanghai Changzheng Hospital

Phase 2 Completed
18 enrolled 7 charts
Plasma cell

Multiple Myeloma

NCT01554852 2018-06-11

Myeloma XI

University of Leeds

Phase 3 Unknown
4,420 enrolled
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00574080 2017-11-20

UARK 2006-15: A Study of Tandem Transplants With or Without Bortezomib and Thalidomide

University of Arkansas

Phase 3 Terminated
20 enrolled 7 charts
Plasma cell

Multiple Myeloma

NCT01868828 2013-06-06

A Study of PAD Versus Velcade, Cyclophosphamide and Dexamethasone (VCD) Treatment in Subjects With Multiple Myeloma

Peking University People's Hospital

Phase 4 Unknown
50 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡